Retatrutide has emerged as a new medication in the fight against obesity. This novel drug, classified as a dual GLP-1 and GIP receptor agonist, shows promising results in research studies. By stimulating these https://allenrlxv445907.laowaiblog.com/35181025/retatrutide-a-promising-new-treatment-for-obesity